Frontier Health

Frontier Health's vision is to establish and provide accessible, high quality care. Frontier Health, a 501(c) 3, is the area’s leading provider of mental health, substance abuse, co-occurring, developmental and intellectual disabilities, recovery and vocational rehabilitation services for adults, children and youth at 64 sites in Northeast Tennessee and Southwest Virginia. Frontier Health's mission is to provide quality services that encourage people to achieve their full potential. To provide those services, Frontier’s 1,005 employees traveled 1.74 million miles during FY 2014-15 in a 12,000-square-mile coverage area for 48,862 individuals. Frontier Health also provides an adult residential treatment for addiction and/or co-occurring disorders, services for individuals who are deaf or hard of hearing, domestic violence victims, youth in crisis, runaways, foster care and adoption services.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

MEDICAL

ABC OPENS COMMERCIAL MEL BIOSURFACTANT PRODUCTION IN IRVINE, CA

ABC | May 19, 2022

news image

Advanced BioCatalytics (ABC) is pleased to announce the opening of our new biosurfactant commercial pilot plant in Irvine California. The plant reflects the successful collaboration of the ABC R&D team and Dr. Wenjie Xia, professor of Microbiology at Nankai University in Tianjin China. The commercial pilot plant is the first step in commercial scale up of new glycolipid (biosurfactants) and is the first plant to produce commercial quantities of mannosylerythritol lipids (MEL) in North Americ...

Read More

BETTERLIFE SCALES UP MANUFACTURING OF AP-003 (INTERFERON ALPHA 2B) TO PREPARE FOR CLINICAL TRIALS

BetterLife Pharma Inc. | September 17, 2020

news image

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced it has entered into an agreement with List Biological Laboratories, Inc. (“List Labs”) for the manufacture of its proprietary interferon alpha 2b for the treatment of COVID-19. "Following our recent merger, we are proud to be continuing the development of Altum Pharmaceutical’s proprietary interferon alpha 2b inh...

Read More

TEVOGEN BIO PARTNERED WITH NEAL FLOMENBERG TO EVALUATE TEVOGEN' S PROPRIETARY ANTIGEN-SPECIFIC T-CELL TECHNOLOGY AS A TREATMENT FOR COVID-19

Tevogen Bio | August 11, 2020

news image

Tevogen Bio believes that its investigational highly purified antigen-specific T cell therapy holds promise in the treatment of viral infections including COVID-19 and Influenza A. This collaboration aims to harness Tevogen's proprietary immunotherapy platform and Dr. Flomenberg's expertise in immunology, histocompatibility and pioneering work in the immunology of stem cell transplantation. Tevogen Bio announces a joint partnership with renowned bone-marrow transplant expert Neal Flomenb...

Read More

INDUSTRIAL IMPACT

INVENTORS OF BIOLAYER INTERFEROMETRY TECHNOLOGY LAUNCH A NEXT GEN PLATFORM AND NOVEL BIOSENSORS

Gator Bio | September 15, 2021

news image

Gator Bio, Inc. announced today the launch of the GatorPlus, a next generation biolayer interferometry (BLI) instrument and two new biosensor products, Gator™ Flex SA Kit and Gator™ AAVX probe. The GatorPlus adds to the currently available GatorPrime instrument; and the new Gator™ Flex SA Kit and Gator™ AAVX probe expand the off the shelf biosensor portfolio to 14 products for the North America market. Gator Bio also offers on demand custom biosensors for specific applica...

Read More
news image

MEDICAL

ABC OPENS COMMERCIAL MEL BIOSURFACTANT PRODUCTION IN IRVINE, CA

ABC | May 19, 2022

Advanced BioCatalytics (ABC) is pleased to announce the opening of our new biosurfactant commercial pilot plant in Irvine California. The plant reflects the successful collaboration of the ABC R&D team and Dr. Wenjie Xia, professor of Microbiology at Nankai University in Tianjin China. The commercial pilot plant is the first step in commercial scale up of new glycolipid (biosurfactants) and is the first plant to produce commercial quantities of mannosylerythritol lipids (MEL) in North Americ...

Read More
news image

BETTERLIFE SCALES UP MANUFACTURING OF AP-003 (INTERFERON ALPHA 2B) TO PREPARE FOR CLINICAL TRIALS

BetterLife Pharma Inc. | September 17, 2020

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced it has entered into an agreement with List Biological Laboratories, Inc. (“List Labs”) for the manufacture of its proprietary interferon alpha 2b for the treatment of COVID-19. "Following our recent merger, we are proud to be continuing the development of Altum Pharmaceutical’s proprietary interferon alpha 2b inh...

Read More
news image

TEVOGEN BIO PARTNERED WITH NEAL FLOMENBERG TO EVALUATE TEVOGEN' S PROPRIETARY ANTIGEN-SPECIFIC T-CELL TECHNOLOGY AS A TREATMENT FOR COVID-19

Tevogen Bio | August 11, 2020

Tevogen Bio believes that its investigational highly purified antigen-specific T cell therapy holds promise in the treatment of viral infections including COVID-19 and Influenza A. This collaboration aims to harness Tevogen's proprietary immunotherapy platform and Dr. Flomenberg's expertise in immunology, histocompatibility and pioneering work in the immunology of stem cell transplantation. Tevogen Bio announces a joint partnership with renowned bone-marrow transplant expert Neal Flomenb...

Read More
news image

INDUSTRIAL IMPACT

INVENTORS OF BIOLAYER INTERFEROMETRY TECHNOLOGY LAUNCH A NEXT GEN PLATFORM AND NOVEL BIOSENSORS

Gator Bio | September 15, 2021

Gator Bio, Inc. announced today the launch of the GatorPlus, a next generation biolayer interferometry (BLI) instrument and two new biosensor products, Gator™ Flex SA Kit and Gator™ AAVX probe. The GatorPlus adds to the currently available GatorPrime instrument; and the new Gator™ Flex SA Kit and Gator™ AAVX probe expand the off the shelf biosensor portfolio to 14 products for the North America market. Gator Bio also offers on demand custom biosensors for specific applica...

Read More